Leading expert in colorectal cancer and gastrointestinal oncology, Dr. Hans-Joachim Schmoll, MD, explains his extensive career and contributions to cancer medicine. He is a professor and director of clinical oncology research in Germany. Dr. Schmoll has published over 400 scientific articles and edited a major 7000-page cancer treatment compendium. His clinical focus includes colorectal, gastrointestinal, genitourinary, and germ cell tumors.
More from Diagnostic Detectives Network
Expert Insights on Colorectal Cancer Treatment and Research
Jump To Section
- Distinguished Career in Oncology
- Clinical and Research Focus Areas
- Major Publications and Editorship
- Leadership in Academic Medicine
- Contributions to Cancer Education
- Full Transcript
Distinguished Career in Oncology
Dr. Hans-Joachim Schmoll, MD, is a prominent oncologist with a long and distinguished career. He is currently the Director of the Clinical Oncology Research Program and a Professor of Medicine at Martin Luther University in Halle-Wittenberg, Germany. Dr. Schmoll's foundational training was completed in hematology and oncology at the Medical University of Hannover.
His career progression includes significant leadership roles. Dr. Schmoll previously served as the director of the Department of Oncology and Hematology. He was also the director of the Center for Cell and Gene Therapy at the same institution.
Clinical and Research Focus Areas
The clinical expertise of Dr. Hans-Joachim Schmoll, MD, covers several key oncology specialties. His primary focus is on the treatment of colorectal cancer. Dr. Schmoll also has deep experience in managing gastrointestinal cancers.
His research and clinical practice extend to genitourinary cancers and germ cell tumors. This broad focus allows for a comprehensive approach to complex cancer cases. Dr. Anton Titov, MD, highlights these specialties in his introduction.
Major Publications and Editorship
Dr. Hans-Joachim Schmoll, MD, is a prolific author in the field of oncology. He has published over 400 peer-reviewed scientific articles on cancer diagnosis and treatment. These publications contribute significantly to the global medical literature.
Perhaps his most renowned contribution is as an editor. Dr. Schmoll has edited more than 15 books on cancer treatment. His most famous work is a massive, nearly 7000-page comprehensive cancer compendium. This essential reference text is widely known in German-speaking countries as "The Schmoll".
Leadership in Academic Medicine
Leadership has been a constant theme in the career of Dr. Hans-Joachim Schmoll, MD. After his training, he ascended to become the Director of the Division of Oncology within the Department of Hematology Oncology at his alma mater. This role placed him at the forefront of academic cancer care and research.
His current directorship of a clinical oncology research program underscores his ongoing commitment to advancing the field. Dr. Anton Titov, MD, notes these accomplishments as a sign of his esteemed reputation.
Contributions to Cancer Education
Beyond direct patient care and research, Dr. Schmoll has made immense contributions to medical education. His edited textbooks serve as foundational resources for oncologists in training and in practice. The scale and detail of "The Schmoll" make it an indispensable tool for clinicians.
This dedication to educating the next generation of physicians ensures his impact on cancer treatment will endure. Dr. Anton Titov, MD, welcomes his expertise for this very reason, valuing his role as an educator and leader.
Full Transcript
Dr. Hans-Joachim Schmoll is a prominent oncologist and colorectal cancer treatment specialist. He is the director of the Clinical Oncology Research Program and Professor of Medicine at Martin Luther University in Halle-Wittenberg, Germany. Dr. Schmoll is best known as the editor of a comprehensive cancer treatment compendium. His clinical and research interests are in colorectal cancer, gastrointestinal cancers, genitourinary cancers, and germline cancers.
Dr. Anton Titov, MD: Hello! We are joined by Prof. Dr. Hans-Joachim Schmoll, MD, a prominent oncologist and colorectal cancer treatment specialist. Dr. Schmoll is the director of the Clinical Oncology Research Program and Professor of Medicine at Martin Luther University in Halle-Wittenberg, Germany.
He is also a former director of the Department of Oncology and Hematology and former director of the Center for Cell and Gene Therapy at Martin Luther University. Dr. Schmoll received his M.D. and trained in hematology oncology at the Medical University of Hannover in Germany.
Prof. Dr. Hans-Joachim Schmoll, MD, then became Director of the Division of Oncology, Department of Hematology Oncology, at the Medical University of Hannover. Dr. Schmoll's clinical and research interests are in colorectal cancer, gastrointestinal cancers, genitourinary cancers, and germline cancers.
Prof. Dr. Hans-Joachim Schmoll, MD, has published over 400 scientific articles on cancer diagnosis and treatment. He is the editor of more than 15 books on cancer treatment.
In the German-speaking countries, Dr. Schmoll is best known as the editor of a comprehensive cancer treatment compendium. This book has almost 7,000 pages and is known as "The Schmoll".
Dr. Anton Titov, MD: Professor Schmoll, hello and welcome!
Dr. Hans-Joachim Schmoll, MD: Hello, pleasure to speak with you.